The Buspirone Market represents the global industry surrounding the production, distribution, and utilization of buspirone-based medications primarily prescribed for anxiety disorders. According to Growth Market Reports, the market is expanding steadily due to increasing awareness of mental health conditions, improved access to treatment, and growing demand for effective anti-anxiety therapies with favorable safety profiles.

growthmarketreports.com

Buspirone Market Size to Hit USD 904.6 Million by 2034 | CAGR 5.9%

The global buspirone market reached USD 540 million in 2025, driven by rising anxiety disorder prevalence and growing mental health awareness worldwide.